SITE009-0073

SITE009 (AUS) › SITE009-0073

SITE009-0073

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2025-11-23

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 3 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 254); relationship: NOT RELATED

severe assessed

Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-02-04 (study day 248); relationship: not assessed

moderate assessed

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-11-21 (study day 173); relationship: not assessed

mild assessed

Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-08-26 (study day 86); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.